Kading Companies' Three Current Technology Companies have the Potential to Penetrate Multi-Billion Dollar Global Markets

NEW YORK - (BUSINESS WIRE) - May 3, 2006 - Kading Companies (Pink Sheets: KDNG www.kadingco.com) announces that the three separate technology companies that are being developed each have the potential to penetrate multi-billion dollar markets and, if successful, could have a substantial impact on the valuation of KDNG.

Kevin Kading, President and CEO and KDNG, during the past eight years, has searched for and acquired three technologies: Syringex Medical's retractable needle safety syringe; Advanced Reconnaissance's reconnaissance and surveillance systems and United Aerospace's NASA - developed coupler system. Each technology has the potential to break into multi-billion dollar markets with, what Kevin Kading believes are innovative, user friendly and potentially cost competitive products.

Unlike a Business Development Company or Investment Company, KDNG differs because KDNG management takes a very active roll in the development of the technology and the new company. Once the technology is acquired through the new corporation, usually incorporated by Kevin Kading, KDNG funds and invites its investors to fund the initial stages of development; initially Kevin Kading is the primary officer and director of the new company. Mr. Kading then works to find others to participate in the management and building of the company, developing the product, searching for market penetration points and building a company that is expected to obtain enough market share to create very substantial value for the investors, management, and KDNG.

Mr. Kading stated, "I believe that the current three companies: Syringex, Advanced Reconnaissance and United Aerospace all have products (www.kadingco.com) that have the potential to capture several percentage points in their overall market space where sales could break through the 100's of millions of dollars over the next several years and that translates into substantial potential values for KDNG." Each global market - medical products, reconnaissance and surveillance and hitches and couplers - is estimated to be in the billions of dollars annually. "Furthermore, I believe that we are much closer to commercialization with many of the products and I believe that 2006 may be the year products from all three companies become available to consumers."

Kevin Kading has already targeted another innovative, literally "nuts and bolts" technology that he believes can penetrate a very substantial market and has begun initial due diligence. Mr. Kading stated, "We intend to continue to seek out and acquire potentially high growth technologies based on our acquisition model."

High Risk - High Reward. Mr. Kading further stated that, "Investing in development stage technologies does create high degrees of risk for investors; however, if the enterprise is successful in its endeavors, the potential reward can far outweigh the risk. I believe the potential returns justify the risk. At KDNG we are looking for 1,000's of percentage returns on our ownership in these companies and that type of anticipated return carries a very hefty degree of risk."

For additional information visit: www.kadingco.com

Statements contained in this press release that are not based upon current or historical fact are forward-looking in nature. Such forward-looking statements reflect the current views of management with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or described pursuant to similar expressions.

CONTACT: Kading Companies, SA (KDNG)
Kevin Kading, 212-918-4535
kkading@kadingco.com